Determination of underivatised efaroxan and idazoxan in blood plasma by capillary gas chromatography with mass-selective detection.
Sensitive and specific methods for the determination of efaroxan and idazoxan in blood plasma have been developed based on solvent extraction, chromatographic separation and quantification by selected-ion monitoring using a quadruple mass-selective detector. The use of a short non-polar bonded-phase capillary gas chromatography (GC) column facilitated rapid separation of the compounds of interest from internal standards, metabolites and endogenous material. Of equal significance was the ability to chromatograph these basic compounds without prior derivatisation. The application of bonded-phase capillary GC coupled to selected-ion monitoring resulted in robust analytical procedures with sub-ng ml(-1) sensitivity and high selectivity.
Nichols
J D
JD
Hyde
N A
NA
Sugden
K
K
D000317:Adrenergic alpha-Antagonists / Q000097:blood*; D001572:Benzofurans / Q000097:blood*; D004146:Dioxanes / Q000097:blood*; D004147:Dioxins / Q000097:blood*; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D019329:Idazoxan; D007093:Imidazoles / Q000097:blood*
D000317:Adrenergic alpha-Antagonists; D001572:Benzofurans; D004146:Dioxanes; D004147:Dioxins; D007093:Imidazoles; C062597:efaroxan; D019329:Idazoxan